Chalkias S, Eder F, Essink B, Khetan S, et al. Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial. Nat Med 2022 Oct 6. pii: 10.1038/s41591-022-02031.
PMID: 36202997